Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-17-006886)

Filing Details

Accession Number:: 0001213900-17-006886
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-28 11:34:33
Reporting Period:: 2017-06-26

Filing Date:: 2017-06-28
Accepted Time:: 2017-06-28 11:34:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1498382	Delmar Pharmaceuticals Inc.	DMPI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1332948	Scott Praill	Suite 720-999 West Broadway Vancouver A1 V5Z 1K5	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-06-26	4,167	$3.60	29,444	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The Reporting Person purchased the shares in a private transaction for an aggregate purchase price of CDN $20,000. Reported price is based on exchange rate of 0.75.